Version 5.4
Bos taurus Protein: CARKL
Summary
InnateDB Protein IDBP-684954.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol CARKL
Protein Name sedoheptulokinase
Synonyms CARKL;
Species Bos taurus
Ensembl Protein ENSBTAP00000001095
InnateDB Gene IDBG-633258 (CARKL)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0016301 kinase activity
GO:0016773 phosphotransferase activity, alcohol group as acceptor
GO:0050277 sedoheptulokinase activity
Biological Process
GO:0005975 carbohydrate metabolic process
GO:0009052 pentose-phosphate shunt, non-oxidative branch
GO:0016310 phosphorylation
GO:0035963 cellular response to interleukin-13
GO:0043030 regulation of macrophage activation
GO:0050727 regulation of inflammatory response
GO:0071222 cellular response to lipopolysaccharide
GO:0071353 cellular response to interleukin-4
Cellular Component
GO:0005737 cytoplasm
Protein Structure and Domains
PDB ID
InterPro IPR018484 Carbohydrate kinase, FGGY, N-terminal
PFAM PF00370
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q1JPE3
UniProt Splice Variant
Entrez Gene 511999
UniGene Bt.14637
RefSeq NP_001069016
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BT025410 DAAA02048691
GenPept ABF57366

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca